Wang T et al., 2024-02-27: Mouse tumour study in which methylene blue-mediated photodynamic therapy released damage-associated molecular patterns, matured dendritic cells, increased antitumour T-cell infiltration and, with a PD-1 inhibitor, prolonged survival in an immune-cold tumour model.
Furthermore, methylene blue (MB)-mediated photodynamic therapy promotes the release of damage-associated molecular patterns (DAMPs), which acts as in situ tumor vaccine and further induces dendritic cells maturation, augments the infiltration of antitumor T cells and significantly impedes the primary tumor growth and proliferation.
Wang T et al., 2024-02-27: Mouse tumour study in which methylene blue-mediated photodynamic therapy released damage-associated molecular patterns, matured dendritic cells, increased antitumour T-cell infiltration and, with a PD-1 inhibitor, prolonged survival in an immune-cold tumour model. C6 Wang 2024. Study type: in vivo mouse tumour model with in vitro immunology; 'functional living materials' FeAu-methylene blue composites. Country: China. Dose/light: not stated in the abstract. Funder: National Natural Science Foundation of China (82061148012, 82027806, 82227808, 21974019) and China Postdoctoral Science Foundation (2022M720724). Conflicts: none declared in the record. Comparator: phototherapy alone vs phototherapy plus anti-PD-1. NOTE: immune activation is shown only for a composite material, not for methylene blue alone. Study type: animal.
